Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
405 participants
INTERVENTIONAL
2009-10-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Management Intervention in College: A Pilot
NCT06994923
Weight Management Skills in African American Outpatients
NCT00146081
Daily Self-Weighing for Obesity Management in Primary Care
NCT04044794
Lifestyle Intervention Program in Overweight Medical Students
NCT03636581
Weight Gain Prevention
NCT00606840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, the SCALE study is in the trial phase. Among overweight or obese Black or Latino adults who live in Harlem or the South Bronx, the primary goal of this project is to achieve weight loss of 7% or more over 12 months by making small sustained changes in eating behavior coupled with sustained increases in physical activity. Participants are enrolled for 12 months and are randomized to one of two study groups.
Group 1: Will choose one of ten small change eating strategies, a physical activity goal and will receive the positive affect/self affirmation component.
Group 2: Will choose one of ten small change eating strategies and a physical activity goal
For inquiries regarding potential enrollment in this study, please contact Rosio Ramos at 646-962-5070 or email [email protected]
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Subjects in will be randomized to the small change eating strategy, a physical activity goal and will receive the positive affect/self affirmation component.
eating/physical activity/positive affect/self-affirmation group.
Group 1
Subjects will be randomized to the small change eating strategy, a physical activity goal and will receive the positive affect/self affirmation component.
Group 2
Subjects will be randomized to the small change eating strategy and a physical activity goal.
eating/physical activity group. No intervention, just the eating strategy and physical activity components.
Group 2
Subjects will be randomized to the small change eating strategy and a physical activity goal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1
Subjects will be randomized to the small change eating strategy, a physical activity goal and will receive the positive affect/self affirmation component.
Group 2
Subjects will be randomized to the small change eating strategy and a physical activity goal.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Black or Latino community-dwelling subjects who are 21 years or older and have a body mass index of \>25 but \<50 or considered to be obese or overweight are be eligible for study participation. All participants must be able to participate in physical activity and Must be fluent in English or Spanish.
Exclusion Criteria
1. Unable to provide informed consent in either English or Spanish for any reason, including cognitive impairment, psychiatric illness, drug or alcohol addiction
2. Pregnant or are planning to become pregnant within the year
3. Participating in another weight loss program or trial
4. On medications for obesity
5. Have a history of bulimia;
6. history of surgery for obesity;
7. Have severe comorbid diseases that can lead to unintentional weight change including cancer, HIV/AIDS, congestive heart failure.
8. They live in an institutional setting (nursing home, prison or group home).
9. Have severe disease or are terminally ill, including stroke, myocardial infarction, coronary artery disease requiring angioplasty.
\-
21 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary E. Charlson, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Charlson, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renaissance Health Care Network
New York, New York, United States
Abyssinian Baptist Church
New York, New York, United States
Metropolitan Methodist Church
New York, New York, United States
Lincoln Medical and Mental Health Center
The Bronx, New York, United States
East Side House Settlement
The Bronx, New York, United States
Iglesia Congregacion Cristiana del Bronx
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Charlson M, Wells M, Devine CM, Watts J, Ramos R, Hollenberg J, Winston G, Phillips E, Wethington E. Interval life events are an important determinant of heterogeneity in outcomes in a randomised trial: a novel, simple method of assessment. BMJ Open. 2024 Jul 30;14(7):e074623. doi: 10.1136/bmjopen-2023-074623.
Phillips EG, Wells MT, Winston G, Ramos R, Devine CM, Wethington E, Peterson JC, Wansink B, Charlson M. Innovative approaches to weight loss in a high-risk population: The small changes and lasting effects (SCALE) trial. Obesity (Silver Spring). 2017 May;25(5):833-841. doi: 10.1002/oby.21780. Epub 2017 Apr 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0908010566
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.